한방재활의학과학회지 (Journal of Korean Medicine Rehabilitation)

  • 제32권1호
  • /
  • Pages.37-49
  • /
  • 2022
  • /
  • 1229-1854(pISSN)
  • /
  • 2288-4114(eISSN)
한방재활의학과학회 (The society of Korean Medicine Rehabilitation)
권호 표지
DOI QR코드

DOI QR Code

폐색성 혈전 혈관염의 침 치료에 대한 체계적 문헌고찰

A Systematic Review of Acupuncture Treatment for Thromboangiitis Obliterans

  • 최지민 (동신대학교 한의과대학 한방재활의학교실) ;
  • 전석희 (동신대학교 목포한방병원 침구과) ;
  • 임용하 (동신대학교 한의과대학 한방재활의학교실) ;
  • 정민재 (동신대학교 한의과대학 한방재활의학교실) ;
  • 김선종 (동신대학교 한의과대학 한방재활의학교실)
  • Choi, Ji Min (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Dongshin University) ;
  • Jeon, Seok Hee (Department of Acupuncture and Moxibustion Medicine, Dongshin University Mokpo Korean Medicine Hospital) ;
  • Lim, Yong Ha (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Dongshin University) ;
  • Jung, Min Jae (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Dongshin University) ;
  • Kim, Seon Jong (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Dongshin University)
  • 투고 : 2021.12.16
  • 심사 : 2021.12.31
  • 발행 : 2022.01.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives The purpose of this study is to present evidence by analyzing the research trends in acupuncture treatment in the last 10 years for thromboangiitis obliterans. Methods Randomized controlled trials about acupuncture on thromboangiitis obliterans were searched China National Knowledge Infrastructure (CNKI), PubMed, EMBASE, Cochrane Library, Oriental Medicine Advanced Searching Integrated System (OASIS), ScienceON, Koreanstudies Information Service System (KISS) and Research Information Sharing Service (RISS) from January 1, 2011 to November 13, 2021. Only randomized controlled trials were selected and we assessed the risk of bias (RoB) according to the revised Cochrane RoB2 criteria. Results A total of 5 randomized controlled trials (RCTs) were selected in this review and all were conducted in China. A total of 326 participants were in 5 RCTs. SP10, ST36, GB34 was the most commonly used treatment point. There were four types of acupuncture used: manual acupuncture, embedding acupuncture, pharmacopuncture, electroacupuncture. The most commonly used indicator for evaluation was the total efficacy rate, and all five studies were significantly higher. Conclusions All selected studies showed the group treated with acupuncture treatments on thromboangiitis obliterans were statistically more effective than the control group. However, the number of studies is too small and the interpretation of the results is limited due to the inclusion of subjective evaluation. So more objective and systematic studies should be conducted continuously.

키워드

과제정보

이 논문은 동신대학교 학술연구비에 의하여 연구되었음.

참고문헌

  1. The Korean Orthopaedic Association. Orthopaedics. 8th ed. Seoul:ChoiSin medical Publishing. 2020:748-9.
  2. Lawrence PF, Lund OI, Jimenez JC, Muttalib R. Substitution of smoke less tobacco for cigarettes in Buerger's disease does not prevent limb loss. Journal of Vascular Surgery. 2008;48(1):210-2. https://doi.org/10.1016/j.jvs.2008.02.007
  3. Korea Centers for Disease Control and Prevention. National Health and Nutrition Survey FACT SHEET: Changes in health behaviors and chronic diseases over 20 years (1998-2018) [Internet] 2020 [cited 2021 Nov 27]. Available from: URL: https://knhanes.cdc.go.kr/knhanes/sub04/sub04_04.do.
  4. Health Insurance Review & Assessment. Disease subdivision (fourth tier of morbidity) statistics [Internet] 2021 [cited 2021 Nov 26]. Available from: URL: http://opendata.hira.or.kr/op/opc/olap4thDsInfo.do.
  5. Eom JY, Chae JS, Ko TH, Son SS, Choi IS. Case of ulcer resulting from buerger's disease improve by acupuncture therapy. The Journal of Korean Acupuncture & Moxibustion Society. 2004;21(4):263-8.
  6. Lee HJ, Lee BY, Lee YE, Yang SB, Cho SY, Park JM, Ko CN, Park SU. Raynaud phenomenon due to Buerger's disease: a case report. The Journal of Internal Korean Medicine. 2015;36(3):427-35.
  7. Kwak BM, Hong KE. Case of buerger's disease improve by Gi-Chim treatment (leech therapy). Journal of Pharmacopuncture. 2009;12(2):91-8. https://doi.org/10.3831/KPI.2009.12.2.091
  8. Lee HS, Cha SJ, Park HJ, Seo JC, Park JB, Lee HJ, Hue MP, Douglas GA, Richard H, Li YP, Wu TX, Adrian W, David M, on behalf of the STRICTA Revision Group. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Korean Journal of Acupuncture. 2010;27(3):1-23.
  9. Sterne JA, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernan MA, Hopewell S, Hrobjartsson A, Junqueira DR, Juni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JP. RoB 2: a revised tool for assessing risk of bias in randomized trials. British Medical Journal. 2019;366:1-8.
  10. Gao J, Duan JH, Li J. Influence of acupoint embedding therapy on clinical efficacy of thromboangiitis obliterans. Journal of Hebei TCM and Pharmacology. 2021;36(2):30-4.
  11. Li C, Luo G. Clinical efficacy of acupuncture combined with oral Chinese medicine in the treatment of thromboangiitis obliterans pain. Journal of Vascular and Endovascular Surgery. 2018;4(6):518-21.
  12. Yu XX. Injection of salvia miltiorrhoza and ligustrazine acupoint injection therapy for the treatment of thromboangiitis obliterans [dissertation]. Harbin:Heilongjiang University of Chinese Medicine; 2018.
  13. Li YH, Cao HQ. Clinical study on acupuncture plus nerve blocking for thromboangiitis obliterans. Shanghai Journal of Acupuncture and Moxibustion. 2014;33(7):627-8. https://doi.org/10.13460/j.issn.1005-0957.2014.07.0627
  14. Zhang Q. Clinical studies of adjuvant therapy electric Jiaji stage I thrombosis obliterans [dissertation]. Harbin: Heilongjiang University of Chinese Medicine; 2014.
  15. McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Research Synthesis Methods. 2021;12(1):55-61. https://doi.org/10.1002/jrsm.1411
  16. Nalluri H, Amishek K, Mohammed AA. Buerger's disease: a segmental nonatherosclerotic inflammatory disorder. International Journal of Pharmaceuticals and Health Care Research. 2015;3(3):79-83.
  17. Park KH, Choi YJ. Medical management of peripheral arterial disease. Korean J Lipidol. 2011;21:46-60.
  18. Shionoya S. Diagnostic criteria of Buerger's disease. International Journal of Cardiology. 1998;66:243-5. https://doi.org/10.1016/S0167-5273(98)00175-2
  19. Choi SH. Current management of peripheral arterial disease. Journal of the Korean Medical Association. 2010;53(3):228-35. https://doi.org/10.5124/jkma.2010.53.3.228
  20. Cacione DG, do Carmo Novaes F, Moreno DH. Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease). Cochrane Database Syst Rev. 2018;10:CD012794.
  21. Gavrilenko AV, Oleinik EM. Comprehensive treatment of a patient with Buerger's disease using genetically engineered complexes VEGF-165. Angiol Sosud Khir. 2019;25(1):177-80. https://doi.org/10.33529/angio2019124
  22. Shin ES, Kim HJ, Kim JS, Son ES, Yu YM. Comparison of clinical efficacy and safety between aspirin and sarpogrelate in patients with arteriosclerosis obliterans. Journal of Korean Society of Health-System Pharmacists. 2020;37(2):190-9. https://doi.org/10.32429/JKSHP.2020.37.2.005
  23. Er KJ, Go YS. A literatural study on the Tal-Juh. The Journal of Oriental Medical Surgery, Ophthalmology & Otolaryngology. 1997;10(1):306-31.
  24. Jeong JJ, Sun SH, Lee YH, Go HY, Jung KY, Song YK, Kim TH, Hong SI, Choi YK, Go SG, Lim EM, Park JH, Jeon CY. Literature review on syndrome differentiation and herbal medicine of thromboangiitis obliterans -focusing on traditional Chinese medicine's journals-. Journal of Physiology & Pathology in Korean Medicine. 2015;29(2):143-51. https://doi.org/10.15188/kjopp.2015.04.29.2.143
  25. Kang AR, Hyun SH, Woo JM, Kim YS, Cho KH, Moon SK, Jung WS. A case study of a thromboangiitis obliterans (Buerger's disease) patient with lower extremity pain and claudication treated by traditional Korean medicine. The Journal of Internal Korean Medicine. 2014;35:271-5.
  26. Editorial Committee. Neo intern handbook. 2nd ed. Paju:Koonja Publishing. 2016:506-8.
  27. Zhang Z, Ji J, Zhang D, Ma M, Sun L. Protective effects and potential mechanism of salvianolic acid B on sodium laurate-induced thromboangiitis obliterans in rats. Phytomedicine. 2020;66:153110. https://doi.org/10.1016/j.phymed.2019.153110
  28. Zheng X, Liu H, Ma M, Ji J, Zhu F, Sun L. Anti-thrombotic activity of phenolic acids obtained from Salvia miltiorrhiza f. alba in TNF-α-stimulated endothelial cells via the NF-κB/JNK/p38 MAPK signaling pathway. Archives of Pharmacal Research. 2021;44:427-38. https://doi.org/10.1007/s12272-021-01325-7
  29. Xu Z, Lu W, Jiang R, Hou B, Deng L, Kuang L, Kuang Z, He Z, Wang J. Observation on the clinical effect of acupuncture around the greater tuberosity of femur combined with acupuncture at Xuehai point to relieve postoperative pain of elderly patients with intertrochanteric fracture of femur. Guizhou University of Traditional Chinese Medicine. 2020;29(2):241-4.
  30. Im JG, Lee HG, Jung DJ, Yook TH, Kim JU. A comparative study of the effects between mountain-burning fire method and heaven-penetrating cooling method at Zusanli (ST36) on thermographic change. The Journal of Korean Acupuncture & Moxibustion Society. 2012;29(2):1-8.
  31. Kang H. Statistical considerations in meta-analysis. Hanyang Medical Reviews. 2015;35:23-32. https://doi.org/10.7599/hmr.2015.35.1.23